会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 93. 发明授权
    • Heart rate variability as an indicator of exercise capacity
    • 心率变异性作为运动能力的指标
    • US06301499B1
    • 2001-10-09
    • US09419659
    • 1999-10-18
    • Gerrard M. CarlsonVeerichetty A. KadhiresanJulio C. Spinelli
    • Gerrard M. CarlsonVeerichetty A. KadhiresanJulio C. Spinelli
    • A61B50456
    • A61N1/365A61B5/0245A61B5/222A61N1/3627A61N1/36514A61N1/36592
    • Based upon patient studies indices a high degree of correlation was found between HRV and VO2max, i.e., the patient's exercise capacity. Based on this finding, a pacing therapy optimization protocol for treating patients with CHF has been devised. The protocol involves first pacing the patient's heart with a pacemaker programmed to operate in a first mode for a predetermined time period and then collecting electrogram data from which a HRV index is derived. The mode is then changed and the steps repeated until all possible modes have been utilized. At that time, a determination is made as to which of the modes is associated with the largest HRV index and the pacemaker is then programmed to function in that mode. Alternatively, the method of the present invention can be applied to changes in drug therapy instead of or in combination with pacing therapy. By the plotting the HRV index computed in the manner described, the efficacy of a change in therapy on patient exercise capacity can be assessed.
    • 根据患者研究指标,发现HRV和VO2max之间存在高度相关性,即患者的运动能力。 基于这一发现,已经设计了用于治疗CHF患者的起搏治疗优化方案。 该方案涉及首先用编程为在第一模式中操作预定时间段的起搏器起搏病人的心脏,然后收集从其导出HRV指数的电描记图数据。 然后改变模式,重复步骤直到所有可能的模式被使用。 此时,确定哪个模式与最大HRV指数相关联,并且起搏器然后被编程为在该模式下起作用。 或者,本发明的方法可以应用于药物治疗的变化,而不是起搏治疗或与起搏治疗组合。 通过绘制以所述方式计算的HRV指数,可以评估治疗改变对患者运动能力的功效。